DE69121464D1 - Verfahren zur Verhütung, Stabilisierung oder Verursachung des Zurückgangs von Atherosklerose durch Anwendung einer Mischung von einem Cholesterol-vermindernden Arzneimittel mit einem ACE-Inhibitor - Google Patents
Verfahren zur Verhütung, Stabilisierung oder Verursachung des Zurückgangs von Atherosklerose durch Anwendung einer Mischung von einem Cholesterol-vermindernden Arzneimittel mit einem ACE-InhibitorInfo
- Publication number
- DE69121464D1 DE69121464D1 DE69121464T DE69121464T DE69121464D1 DE 69121464 D1 DE69121464 D1 DE 69121464D1 DE 69121464 T DE69121464 T DE 69121464T DE 69121464 T DE69121464 T DE 69121464T DE 69121464 D1 DE69121464 D1 DE 69121464D1
- Authority
- DE
- Germany
- Prior art keywords
- atherosclerosis
- cholesterol
- ace inhibitor
- decline
- stabilizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52426690A | 1990-05-15 | 1990-05-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69121464D1 true DE69121464D1 (de) | 1996-09-26 |
DE69121464T2 DE69121464T2 (de) | 1997-03-27 |
Family
ID=24088484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69121464T Expired - Lifetime DE69121464T2 (de) | 1990-05-15 | 1991-05-10 | Verfahren zur Verhütung, Stabilisierung oder Verursachung des Zurückgangs von Atherosklerose durch Anwendung einer Mischung von einem Cholesterol-vermindernden Arzneimittel mit einem ACE-Inhibitor |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0457514B1 (de) |
JP (1) | JPH04226921A (de) |
KR (1) | KR100200467B1 (de) |
AT (1) | ATE141514T1 (de) |
AU (1) | AU651579B2 (de) |
CA (1) | CA2040865C (de) |
DE (1) | DE69121464T2 (de) |
DK (1) | DK0457514T3 (de) |
ES (1) | ES2090244T3 (de) |
GR (1) | GR3021703T3 (de) |
HU (1) | HU212102B (de) |
IE (1) | IE77637B1 (de) |
NZ (1) | NZ237929A (de) |
PT (1) | PT97660B (de) |
ZA (1) | ZA913509B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5157025A (en) * | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
WO1993013801A1 (en) * | 1992-01-17 | 1993-07-22 | The Procter & Gamble Company | Treatment for atherosclerosis |
AU1095695A (en) * | 1993-11-09 | 1995-05-29 | Brigham And Women's Hospital | Hmg-coa reductase inhibitors in the normalization of vascular endothelial dysfunction |
DE4402379C2 (de) * | 1994-01-27 | 1997-09-25 | Lohmann Therapie Syst Lts | Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung |
WO1995026188A1 (en) * | 1994-03-29 | 1995-10-05 | Merck & Co., Inc. | Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
EP1514543A1 (de) | 1997-08-29 | 2005-03-16 | Pfizer Inc. | Kombinationstherapie, enthaltend Atorvastatin und blutdrucksenkendes Mittel |
SI20305A (sl) | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
AU2007200367B2 (en) * | 1999-02-06 | 2010-04-08 | Astrazeneca Ab | Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
GB0001662D0 (en) | 1999-02-06 | 2000-03-15 | Zeneca Ltd | Pharmaceutical compositions |
US6172441B1 (en) | 1999-06-28 | 2001-01-09 | Visteon Global Technologies, Inc. | Rotor assembly |
DE60022525T2 (de) | 1999-08-30 | 2006-06-14 | Sanofi Aventis Deutschland | Ramipril zur vorbeugung von kardiovaskulären vorfällen |
US6576256B2 (en) | 2001-08-28 | 2003-06-10 | The Brigham And Women's Hospital, Inc. | Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US6669955B2 (en) | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
WO2003092729A1 (de) * | 2002-05-03 | 2003-11-13 | Hexal Ag | Stabile pharmazeutische formulierung für eine kombination aus einem statin mit einem ace-hemmer |
AR040588A1 (es) | 2002-07-26 | 2005-04-13 | Schering Corp | Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa |
ATE418551T1 (de) | 2003-03-07 | 2009-01-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
DE602004016123D1 (de) | 2003-03-07 | 2008-10-09 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
WO2004085448A2 (en) * | 2003-03-19 | 2004-10-07 | Genzyme Corporation | Unsaturated phosphinyl-phosphonate phosphate transport inhibitors |
GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
CN1903364B (zh) * | 2005-07-26 | 2011-06-22 | 安徽省现代中药研究中心 | 含有血管紧张素转化酶抑制剂和苯氧酸类化合物的药物组合物 |
US20100173936A1 (en) * | 2008-12-01 | 2010-07-08 | Khan Bobby V | Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system-related disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3536687A1 (de) * | 1985-10-15 | 1987-04-16 | Hoechst Ag | Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit |
-
1991
- 1991-04-19 CA CA002040865A patent/CA2040865C/en not_active Expired - Lifetime
- 1991-04-24 NZ NZ237929A patent/NZ237929A/en unknown
- 1991-04-26 AU AU76270/91A patent/AU651579B2/en not_active Expired
- 1991-04-29 IE IE143191A patent/IE77637B1/en not_active IP Right Cessation
- 1991-05-08 ZA ZA913509A patent/ZA913509B/xx unknown
- 1991-05-10 EP EP91304232A patent/EP0457514B1/de not_active Expired - Lifetime
- 1991-05-10 DK DK91304232.1T patent/DK0457514T3/da active
- 1991-05-10 AT AT91304232T patent/ATE141514T1/de not_active IP Right Cessation
- 1991-05-10 DE DE69121464T patent/DE69121464T2/de not_active Expired - Lifetime
- 1991-05-10 ES ES91304232T patent/ES2090244T3/es not_active Expired - Lifetime
- 1991-05-14 HU HU911620A patent/HU212102B/hu unknown
- 1991-05-14 PT PT97660A patent/PT97660B/pt not_active IP Right Cessation
- 1991-05-14 KR KR1019910007749A patent/KR100200467B1/ko not_active IP Right Cessation
- 1991-05-15 JP JP3110268A patent/JPH04226921A/ja not_active Withdrawn
-
1996
- 1996-11-19 GR GR960403096T patent/GR3021703T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE141514T1 (de) | 1996-09-15 |
PT97660B (pt) | 1998-09-30 |
ZA913509B (en) | 1992-02-26 |
EP0457514A1 (de) | 1991-11-21 |
NZ237929A (en) | 1997-06-24 |
HU212102B (en) | 1996-02-28 |
CA2040865C (en) | 2002-07-23 |
JPH04226921A (ja) | 1992-08-17 |
PT97660A (pt) | 1992-02-28 |
DK0457514T3 (da) | 1996-09-16 |
HUT57993A (en) | 1992-01-28 |
KR910019614A (ko) | 1991-12-19 |
EP0457514B1 (de) | 1996-08-21 |
GR3021703T3 (en) | 1997-02-28 |
ES2090244T3 (es) | 1996-10-16 |
IE911431A1 (en) | 1991-11-20 |
AU7627091A (en) | 1991-11-21 |
HU911620D0 (en) | 1991-11-28 |
IE77637B1 (en) | 1997-12-31 |
KR100200467B1 (ko) | 1999-06-15 |
CA2040865A1 (en) | 1991-11-16 |
AU651579B2 (en) | 1994-07-28 |
DE69121464T2 (de) | 1997-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69121464T2 (de) | Verfahren zur Verhütung, Stabilisierung oder Verursachung des Zurückgangs von Atherosklerose durch Anwendung einer Mischung von einem Cholesterol-vermindernden Arzneimittel mit einem ACE-Inhibitor | |
DE69628874D1 (de) | Verwendung eines HMG CoA-Reduktase Inhibitors zur Vorbeugung eines zweiten Herzanfalls | |
ATE161536T1 (de) | Neue mercaptoacetylamid-derivate zur verwendung als enkephalinase- und ace-hemmer | |
DE69324689D1 (de) | Verwendung von diacylglycerolen zur steigerung des melaningehaltes in melanozyten | |
DE69115909D1 (de) | Verwendung von Phospholipiden zur Herstellung eines topischen Arzneimittels zur Beinflussung des Serumcholesterinspiegels | |
DE69600084T2 (de) | Verwendung von hydroxylierte Carbonsäure zur Behandlung von Nägeln | |
DE69428403D1 (de) | Verfahren zur Herstellung von Azetidinverbindungen und Ausgangsverbindungen dafür | |
DE69306915T2 (de) | Kombination zur Detektion von Weichgewebeanomalien | |
ATE142884T1 (de) | Verwendung von magnesium-pyridoxal-5'-phosphat- glutaminat zur verhinderung von krankheiten verursacht durch gefässläsionen | |
MD960168A (ro) | Metodă şi compuşi pentru tratamentul infecţiilor virale | |
EP0321221A3 (de) | Methode zur Vorbeugung oder Behandlung von Angstzuständen unter Einsatz eines ACE-Hemmstoffes | |
DE3773059D1 (de) | Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien. | |
EP0381074A3 (de) | Verfahren zur Diäterleichterung unter Verwendung eines ACE-Inhibitors | |
DE59408420D1 (de) | Niedrigviskose kosmetische und pharmazeutische emulsionen | |
DE59402901D1 (de) | Verfahren zur Herstellung von 5-Fluoranthranilsäurealkylestern und/oder 5-Fluoranthranilsäure | |
DE69131058D1 (de) | Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis | |
ATE107166T1 (de) | Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. | |
DE69422953T2 (de) | Verfahren zur Herstellung von D-Milchsäure und L-Lactamid | |
BR9813539A (pt) | Combinações de inibidor de lp(a) e estatina anti-hiperlipidêmicas | |
DE59203472D1 (de) | Verwendung von dl-valin, dessen estern und/oder salzen zur bekämpfung von kopfschuppen. | |
DE69402241D1 (de) | Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens | |
DE59301706D1 (de) | Verfahren zur Herstellung von Copolymerisaten des Ethylens mit Acrylsäure oder Gemischen von Acrylsäure oder Gemischen von Acrylsäure mit Acrylsäureestern | |
ATE99062T1 (de) | Verfahren zur kontinuierlichen und selbsttaetigen durchfuehrung von analysen und anordnung zur durchfuehrung des verfahrens. | |
DE59307241D1 (de) | Verfahren zur Herstellung von Diarylcarbonaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |